Differential expression of the topoisomerase IIa and IIb genes in human breast cancers
1996

Topoisomerase II Expression in Breast Cancer

Sample size: 56 publication Evidence: moderate

Author Information

Author(s): MI Sandri, D Hochhauser, P Ayton, RC Camplejohn, R Whitehouse, H Turley, K Gatter, ID Hickson, AL Harris

Primary Institution: Imperial Cancer Research Fund, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK

Hypothesis

The study aims to assess the relationship between the expression of topoisomerase II isoforms and established prognostic factors in breast cancer.

Conclusion

High expression of topoisomerase IIa is significantly associated with a high S-phase fraction, which correlates with poor overall survival in breast cancer patients.

Supporting Evidence

  • High topoisomerase IIa gene expression was significantly associated with a high S-phase fraction.
  • An S-phase fraction greater than 10% was associated with poor overall survival.
  • Topoisomerase II expression showed a log-normal distribution in the samples analyzed.

Takeaway

This study looked at how much of a certain protein, topoisomerase II, is found in breast cancer samples and how it relates to how fast the cancer is growing and how well patients do.

Methodology

The study involved analyzing mRNA expression levels of topoisomerase II isoforms in breast tumor samples using ribonuclease protection assays and correlating these levels with S-phase fraction and other prognostic factors.

Limitations

The study did not find a correlation between topoisomerase II expression and other prognostic factors such as age, nodal status, or tumor size.

Participant Demographics

Patients undergoing breast surgery at the John Radcliffe Hospital, Oxford, UK.

Statistical Information

P-Value

0.01

Confidence Interval

1.12-1.58

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication